Shanghai Pukang Pharmaceutical

Shanghai Pukang Pharmaceutical is a China-based pharmaceutical company focused on the development and manufacture of chemical drug products, with commercialized oral solid formulations and bioequivalence-stage generic programs. The company was founded in 1993 and operates in Shanghai, where it manufactures tablets and hard capsules under GMP requirements. Publicly available sources indicate marketed or core products including captopril tablets, cefradine capsules, ofloxacin capsules, Ningxinbao capsules, and coenzyme Q10 capsules, and the company has run bioequivalence studies for rivaroxaban and metformin extended-release tablets. It also appears to maintain an R&D team and laboratory presence in Nanjing. Overall, the company looks like an active Chinese small-molecule pharma manufacturer centered on generic and reformulated products rather than an innovation-stage biotech.